Differential effects of AdOx on gene expression in P19 embryonal carcinoma cells

• Main Authors: Yan Li, Zhao Hai-yong, Zhang Ye, Shen Yu-fei
• Format: Article
• Language: English
• Published: BMC 2012-01-01
• Series: BMC Neuroscience
• Online Access: http://www.biomedcentral.com/1471-2202/13/6

<p>Abstract</p> <p>Background</p> <p>Pluripotent cells maintain a unique gene expression pattern and specific chromatin signature. In this study, we explored the effect of the methyltransferase inhibitor adenosine dialdehyde (AdOx) on pluripotency maintenance and gene expression in P19 embryonal carcinoma cells.</p> <p>Results</p> <p>After AdOx treatment, the pluripotency-related gene network became disordered, and the early developmental genes were released from the repression. Remarkably, AdOx caused contrasting effects on the expression of two key pluripotency genes, <it>nanog </it>and <it>oct3/4</it>, with the reduction of the repressive histone marks H3K27me3, H3K9me3 and H3K9me2 only in the <it>nanog </it>gene.</p> <p>Conclusions</p> <p>Key pluripotency genes were controlled by different mechanisms, including the differential enrichment of repressive histone methylation marks. These data provided novel clues regarding the critical role of histone methylation in the maintenance of pluripotency and the determination of cell fate in P19 pluripotent cells.</p>